Get to know our clinical trials
Trial of INCB106385 in monotherapy or in combination with immunotherapy in participants with advanced solid tumors.
THE AIM OF THIS STUDY IS TO TEST THE SAFETY AND TOLERABILITY OF MONOTHERAPY AND COMBINATION THERAPY, TO FIND OUT WHAT EFFECTS, IF ANY, THESE THERAPIES HAVE ON PEOPLE AND THEIR CANCER AND TO SELECT THE SAFE AND TOLERABLE DOSE OF INCB106385 TO BE STUDIED FURTHER AS MONOTHERAPY OR COMBINATION THERAPY.
- Code EudraCT: 2020-002921-27
- Protocol number: INCB 106385-102
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.